Join Now

Category Archives: BioUtah News

Audio-based Detection of Anxiety and Depression via Vocal Biomarkers

By Natalie Themm | Published September 28, 2023

Audio-based Detection of Anxiety and Depression via Vocal Biomarkers

| Tagged | Comments Off on Audio-based Detection of Anxiety and Depression via Vocal Biomarkers

bioMérieux submits Dual 510(k) and CLIA-waiver application to FDA for the BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel

By Natalie Themm | Published September 28, 2023

Marcy-l’Étoile (France), September 22nd, 2023 – bioMérieux, a world leader in the field of in vitro diagnostics, has submitted the BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel to U.S. Food and Drug Administration (FDA) for a dual 510(k) clearance and CLIA1-waiver. This panel is already CE-marked (IVDD2).

| Tagged | Comments Off on bioMérieux submits Dual 510(k) and CLIA-waiver application to FDA for the BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel

Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

By admin | Published September 21, 2023

Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only test SALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic partnership with Illumina Inc. (NASDAQ: ILMN), a global leader in […]

| Comments Off on Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

Myriad Genetics Issues 2022 Environmental, Social and Governance Report

By admin | Published September 21, 2023

SALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today released its second annual Environmental, Social and Governance report, highlighting key efforts that reflect its commitment to conduct operations as a responsible, equitable and sustainable partner in the healthcare industry. “At Myriad, […]

| Comments Off on Myriad Genetics Issues 2022 Environmental, Social and Governance Report

Rep. Moore’s Health Staff Visits Utah Life Sciences Companies

By Natalie Themm | Published September 21, 2023

Rep. Moore’s Health Staff Tours Visits Utah Life Sciences Companies

| Comments Off on Rep. Moore’s Health Staff Visits Utah Life Sciences Companies

Partnership and innovation help SSM Health secure lower-cost, reliable supply of generic drugs

By Natalie Themm | Published September 21, 2023

Civica Rx, a health care utility co-founded by SSM Health, supplies critical medications that patients need.

| Tagged | Comments Off on Partnership and innovation help SSM Health secure lower-cost, reliable supply of generic drugs

GE HealthCare Awarded a $44 Million Grant to Develop Artificial Intelligence-Assisted Ultrasound Technology Aimed at Improving Outcomes in Low-and-Middle-Income Countries

By Natalie Themm | Published September 21, 2023

rant from Bill & Melinda Gates Foundation will facilitate development of AI-assisted applications and tools

| Tagged | Comments Off on GE HealthCare Awarded a $44 Million Grant to Develop Artificial Intelligence-Assisted Ultrasound Technology Aimed at Improving Outcomes in Low-and-Middle-Income Countries

BioUtah, Life Sciences Innovators Take Stage at Legislature’s Interim Meeting

By Natalie Themm | Published September 21, 2023

The Utah Life Sciences Innovation Caucus hosted a lunch for all legislators during the September 18.

| Comments Off on BioUtah, Life Sciences Innovators Take Stage at Legislature’s Interim Meeting

NUSANO APPOINTS INDUSTRY EXPERT ALEXANDRE GIBIM AS CHIEF OPERATIONS OFFICER

By Natalie Themm | Published September 21, 2023

EXECUTIVE WITH THREE DECADES OF SUCCESSFUL MULTINATIONAL OPERATIONS AND COMMERCIAL EXPERIENCE TO LEAD LAUNCH OF PROPRIETARY RADIOISOTOPE PRODUCTION PLATFORM

| Tagged | Comments Off on NUSANO APPOINTS INDUSTRY EXPERT ALEXANDRE GIBIM AS CHIEF OPERATIONS OFFICER

BioUtah Participates in American Cancer Society Policy Panel Presentation

By Natalie Themm | Published September 14, 2023

Kelvyn Cullimore, BioUtah’s CEO, participated as a panelist.

| Comments Off on BioUtah Participates in American Cancer Society Policy Panel Presentation

Merit Medical Launches the Aspira® Evacuated Drainage Bottle

By Natalie Themm | Published September 7, 2023

Advanced design complements comprehensive drainage portfolio, expanding compassionate at-home treatment options to more patients

| Tagged | Comments Off on Merit Medical Launches the Aspira® Evacuated Drainage Bottle

Recursion Announces Completion of Phase 1 Study for REC-3964 for Clostridioides Difficile Infection

By Natalie Themm | Published September 7, 2023

REC-3964 has been well tolerated in healthy volunteers with no reported serious adverse events. Recursion to explore initiating a Phase 2 proof-of-concept study in patients with recurrent Clostridioides difficile infection in 2024.

| Tagged | Comments Off on Recursion Announces Completion of Phase 1 Study for REC-3964 for Clostridioides Difficile Infection

A Special Thanks To Our Legacy and Platinum Elite Members